Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
Cencora lifts annual profit view on strong demand for specialty medicines
FTC takes closer look at Cencora-Covetrus animal health merger, Bloomberg News reports
Kultura Brands Reports Strong Commercial Momentum Following Successful Participation at Cencora ThoughtSpot 2026
Cencora revises forecast for 2026, approves $2 billion share buyback